The FDA met last week in the first hearing to decide the regulatory fate of the cannabinoid CBD; you know the marijuana component that has no or little psychoactive effect. At the most basic of levels, a drug is a chemical.
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
